RU97108766A - METHOD FOR TREATING TOXIC-SEPTIC CONDITIONS IN NEWBORN CHILDREN - Google Patents

METHOD FOR TREATING TOXIC-SEPTIC CONDITIONS IN NEWBORN CHILDREN

Info

Publication number
RU97108766A
RU97108766A RU97108766/14A RU97108766A RU97108766A RU 97108766 A RU97108766 A RU 97108766A RU 97108766/14 A RU97108766/14 A RU 97108766/14A RU 97108766 A RU97108766 A RU 97108766A RU 97108766 A RU97108766 A RU 97108766A
Authority
RU
Russia
Prior art keywords
treating toxic
septic conditions
newborn children
septic
conditions
Prior art date
Application number
RU97108766/14A
Other languages
Russian (ru)
Other versions
RU2144837C1 (en
Inventor
И.П. Коренков
Ю.И. Бобков
М.С. Ефимов
А.И. Александрова
Ю.Ф. Бельчик
Original Assignee
Российская медицинская академия последипломного образования Министерства здравоохранения РФ
Filing date
Publication date
Application filed by Российская медицинская академия последипломного образования Министерства здравоохранения РФ filed Critical Российская медицинская академия последипломного образования Министерства здравоохранения РФ
Priority to RU97108766A priority Critical patent/RU2144837C1/en
Priority claimed from RU97108766A external-priority patent/RU2144837C1/en
Publication of RU97108766A publication Critical patent/RU97108766A/en
Application granted granted Critical
Publication of RU2144837C1 publication Critical patent/RU2144837C1/en

Links

Claims (1)

Способ лечения токсико-септических состояний у новорожденных детей, включающий введение антибактериальных препаратов и 5% раствора глюкозы, отличающийся тем, что раствор глюкозы предварительно облучают рентгеновским излучением в дозе 0,2 - 0,5 Гр/мл, а его введение осуществляют непосредственно до или после или одновременно с введением антибактериальных препаратов.A method of treating toxic-septic conditions in newborns, including the introduction of antibacterial drugs and a 5% glucose solution, characterized in that the glucose solution is pre-irradiated with X-ray at a dose of 0.2 - 0.5 Gy / ml, and its administration is carried out immediately before or after or simultaneously with the introduction of antibacterial drugs.
RU97108766A 1997-06-04 1997-06-04 Method for treating toxic septic states in newborn children RU2144837C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97108766A RU2144837C1 (en) 1997-06-04 1997-06-04 Method for treating toxic septic states in newborn children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97108766A RU2144837C1 (en) 1997-06-04 1997-06-04 Method for treating toxic septic states in newborn children

Publications (2)

Publication Number Publication Date
RU97108766A true RU97108766A (en) 1999-06-10
RU2144837C1 RU2144837C1 (en) 2000-01-27

Family

ID=20193419

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97108766A RU2144837C1 (en) 1997-06-04 1997-06-04 Method for treating toxic septic states in newborn children

Country Status (1)

Country Link
RU (1) RU2144837C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2491088C2 (en) * 2010-11-19 2013-08-27 Сергей Викторович Минаев Method of treating depressed cases in newborns with surgical pathology

Similar Documents

Publication Publication Date Title
DK642587D0 (en) INSULIN PREPARATION
SE8803087L (en) A NEW SET FOR TREATMENT OF ERECT DYSFUNCTION
DE3871822T2 (en) MEDICAL BAG AND MANUFACTURING METHOD.
PT78732B (en) 13-ALPHA-ALKYLGONANEES THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
DE69013797D1 (en) Brain-specific preparation with controlled delivery.
Seidel et al. Sleepiness in insomnia: Evaluation and treatment.
SU556805A1 (en) Method of administering drugs
RU92004357A (en) AMIDA DERIVATIVES N-PHENYL-2-CYANO-3-OXYCROTONIC ACID AND THEIR APPLICATION AS AN IMMUNOMODULATIVE MEDICATION
DE68902300D1 (en) PHARMACEUTICAL SOLUTION CONTAINING SALBUTAMOL AND CROMOGLYCIN ACID.
EP0429522A4 (en) Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
RU97108766A (en) METHOD FOR TREATING TOXIC-SEPTIC CONDITIONS IN NEWBORN CHILDREN
IL88608A0 (en) 3-hydroxy-2-(4-methoxyphenyl)-5-(2-methylaminoethyl)-2-3,dihydro-5h-1,5-benzothiazepin-4-one derivatives,their preparation and their application in therapy
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
Peabody et al. Thyrotropin-releasing hormone (TRH) and Alzheimer's disease.
DE68901172D1 (en) (-) - 2-PYRAZOLINE COMPOUND, THEIR OPTICAL UNLOCKING AND THERAPEUTIC AGENT FOR THE TREATMENT OF CEREBRAL VEGETABLE DISEASES, CONTAINING THIS COMPOUND AS AN ACTIVE INGREDIENT.
FR2605008B1 (en) IMIDAZO (4,5-B) PYRIDINONE-2 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
Astington Talking it over with my brain.
FR2606409B1 (en) IMIDAZOPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
Buesa et al. Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group
KR880002521A (en) Pharmaceutical formulation
RU96114429A (en) METHOD FOR NORMALIZING PHYSIOLOGICAL STATE IN LEVIN
Krasnyuk et al. Treatment of cardiovascular disorders developing in exposure to toxic agents.
Tham et al. Serum amylase in patients treated with lithium.
FR2604434B1 (en) 2-AMINO ETHANETHIOL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
罗和春 et al. ELECTRO-ACUPUNCTURE VS. AMITRIPTYLINE IN THE TREATMENT OF DEPRESSIVE STATES